+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Other Building Blocks 70933-58-3
70933-58-3,MFCD00831583
Catalog No.:AA0062S5

70933-58-3 | N-(3-Ethynylphenyl)acetamide

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
98%
in stock  
$38.00   $27.00
- +
1g
98%
in stock  
$54.00   $38.00
- +
5g
98%
in stock  
$211.00   $148.00
- +
25g
98%
in stock  
$610.00   $427.00
- +
100g
98%
in stock  
$1,640.00   $1,148.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA0062S5
Chemical Name:
N-(3-Ethynylphenyl)acetamide
CAS Number:
70933-58-3
Molecular Formula:
C10H9NO
Molecular Weight:
159.1846
MDL Number:
MFCD00831583
SMILES:
C#Cc1cccc(c1)NC(=O)C
Properties
Properties
 
Form:
Solid  
Storage:
Keep in dry area;2-8℃;  

Computed Properties
 
Complexity:
213  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
2  
XLogP3:
1.6  

Downstream Synthesis Route

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US2003/220371,2003,A1

[1]CurrentPatentAssignee:JOHNSON&JOHNSONINC-US4652584,1987,A

[2]CurrentPatentAssignee:GOVERNMENTOFTHEUNITEDSTATES-US4162265,1979,A

[1]CurrentPatentAssignee:DICCORP.-EP834499,1998,A1

[2]CurrentPatentAssignee:DICCORP.-EP834499,1998,A1

[1]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2007/14707,2007,A1Locationinpatent:Page/Pagecolumn20

[2]CurrentPatentAssignee:ROCHEHOLDINGAG-US2008/39460,2008,A1Locationinpatent:Page/Pagecolumn15

[3]CurrentPatentAssignee:ROCHEHOLDINGAG-US2008/9492,2008,A1Locationinpatent:Page/Pagecolumn18

[1]Jordan,RobertS.;Li,YolandaL.;Lin,Cheng-Wei;McCurdy,RyanD.;Lin,JaniceB.;Brosmer,JonathanL.;Marsh,KristoferL.;Khan,SaeedI.;Houk;Kaner,RichardB.;Rubin,Yves[JournaloftheAmericanChemicalSociety,2017,vol.139,#44,p.15878-15890]

[2]Locationinpatent:experimentalpartGerrard,SimonR.;Edrees,MastouraM.;Bouamaied,Imenne;Fox,KeithR.;Brown,Tom[OrganicandBiomolecularChemistry,2010,vol.8,#22,p.5087-5096]

[3]Gerrard,SimonR.;Srinivasan,Natarajan;Fox,KeithR.;Brown,Tom[Nucleosides,nucleotidesandnucleicacids,2007,vol.26,#10-12,p.1363-1367]

[4]CurrentPatentAssignee:NERVIANOMEDICALSCIENCESS.R.L.-WO2014/184069,2014,A1Locationinpatent:Page/Pagecolumn44

[5]Lv,Yunhe;Pu,Weiya;Chen,Qian;Wang,Qingqing;Niu,Jiejie;Zhang,Qian[JournalofOrganicChemistry,2017,vol.82,#15,p.8282-8289]

[6]CurrentPatentAssignee:WUXIAPPTECCO.,LTD.-WO2010/111483,2010,A1Locationinpatent:Page/Pagecolumn127

[7]CurrentPatentAssignee:MERCK&COINC;WUXIAPPTECCO.,LTD.-US2019/127365,2019,A1Locationinpatent:Paragraph0810-0811

Literature

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 70933-58-3
Building Blocks
More >
Tags:70933-58-3 Molecular Formula|70933-58-3 MDL|70933-58-3 SMILES|70933-58-3 N-(3-Ethynylphenyl)acetamide